Detalhe da pesquisa
1.
Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients.
Infect Dis Ther
; 12(7): 1849-1860, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329414
2.
Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study.
Adv Ther
; 40(8): 3465-3477, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285080
3.
Awareness and Epidemiology of Chronic Hepatitis C Virus Infections in Florida.
Infect Dis Ther
; 11(1): 451-462, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914078
4.
Comparative effectiveness of paricalcitol versus cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
Nephron Clin Pract
; 117(2): c151-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-20699620
5.
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019.
Adv Ther
; 38(12): 5777-5790, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34704194
6.
Cost Effectiveness of Paricalcitol versus a non-selective vitamin D receptor activator for secondary hyperparathyroidism in the UK: a chronic kidney disease markov model.
Clin Drug Investig
; 30(8): 545-57, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20586517
7.
Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection.
Adv Ther
; 37(5): 2267-2274, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279176
8.
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
Value Health
; 12(8): 1086-99, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19744291
9.
Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients.
Nephron Clin Pract
; 113(1): c54-61, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19590235
10.
Development of a Comprehensive Dataset of Hepatitis C Patients and Examination of Disease Epidemiology in the United States, 2013-2016.
Adv Ther
; 35(7): 1087-1102, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29949038
11.
Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis.
Clin Drug Investig
; 26(11): 629-38, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17163297
12.
The wider public health value of HCV treatment accrued by liver transplant recipients.
Am J Manag Care
; 22(6 Spec No.): SP212-9, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27266951
13.
Value of expanding HCV screening and treatment policies in the United States.
Am J Manag Care
; 22(6 Spec No.): SP227-35, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27266953
14.
Costs and spillover effects of private insurers' coverage of hepatitis C treatment.
Am J Manag Care
; 22(6 Spec No.): SP236-44, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27266954
15.
Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US.
J Med Econ
; 19(8): 795-805, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27063573
16.
Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV).
Adv Ther
; 32(11): 1117-27, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538232
17.
Medical resource use and costs related to central precocious puberty: a retrospective cohort study.
Endocr Pract
; 18(4): 519-28, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22440983
18.
Add-back therapy use and its impact on LA persistence in patients with endometriosis.
Curr Med Res Opin
; 26(3): 729-36, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20092387
19.
Chronic kidney disease Markov model comparing paricalcitol to calcitriol for secondary hyperparathyroidism: a US perspective.
Curr Med Res Opin
; 25(5): 1221-34, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19335321
20.
Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings.
Nephrol Dial Transplant
; 19(5): 1174-81, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15004264